Sabine Allard

Sabine Allard is a Physician Scientist at Vrije Universiteit Brussel, working within the Faculty of Medicine and Pharmacy's Department of Internal Medicine. She serves as Coordinating Internship Supervisor for Internal Medicine at UZ Brussel (Universitair Ziekenhuis Brussel), located at Laarbeeklaan 101, 1090 Jette, Belgium. With an MD/PhD qualification, Dr. Allard leads the Vitality Research Group focused on Observational Clinical Sciences.

Her primary research interests include Infectious Diseases, HIV Research, Immunology, Vaccine Development, and Internal Medicine. Dr. Allard specializes in the immunology of HIV and COVID infections, with specific expertise in in vitro and in vivo NK cell activity, HIV-specific T-cell responses, therapeutic HIV vaccines targeting dendritic cells, and mRNA vaccines. Her work also encompasses General Internal Medicine, Infectious Diseases, HIV reference center operations, S clinic management, and Travel medicine. Research fingerprint analysis shows strong emphasis on Dendritic Cells (100%), HIV-1 (75%), HIV (66%), T-lymphocytes (54%), Vaccination (38%), Vaccines (38%), trimix (33%), and Messenger RNA (31%).

Dr. Allard's publication record spans from 2004 to 2025, with 128 research outputs including 72 articles, 25 posters, and 15 meeting abstracts. Her recent work demonstrates a strong focus on HIV treatment challenges, emerging infectious disease outbreaks (including Mpox), antimicrobial resistance patterns, and immune responses in immunocompromised populations. She maintains an h-index of 18 with 1,058 citations according to Scopus data.

• Active participation in PhD committees as jury member
• Chair of the 7th Breach spring meeting on 'HIV Cure' (2024)
• Member of the Hoge Raad van artsen-specialisten (2024)
• Participant in Gilead's Post-CROI Advisory board (2024)
• Chair of AIDA International Seminar (2024)

Dr. Allard leads or participates in multiple significant research projects including ESCAPE (mRNA nanoformulation), ANI370 (HIV reservoir characterization), SRP86 (host-pathogen interactions), OZR3977 (infectious disease mechanisms), and FWOSBO64 (pandemic preparedness using AI models). Her work bridges clinical practice with fundamental and translational research, particularly in the context of pandemic response and emerging infectious threats.